Skip to main content

ADVERTISEMENT

Amplatzer septal occluder

Original Contribution
11/01/2021

Carmine Musto, PhD; Alberta Cifarelli, MD;  Francesco Dipasquale, MD; Diana Chin, PhD; Marco Stefano Nazzaro, PhD; Rocco Edoardo Stio, PhD; Mauro Pennacchi, PhD; Francesco De Felice, MD

Carmine Musto, PhD; Alberta Cifarelli...
Dr. Musto and colleagues evaluate the short- and long-term clinical and echocardiographic outcomes of the percutaneous closure of the patent foramen ovale (PFO) with an atrial septal aneurysm (ASA) using 2 different devices.
Dr. Musto and colleagues evaluate the short- and long-term clinical and echocardiographic outcomes of the percutaneous closure of the patent foramen ovale (PFO) with an atrial septal aneurysm (ASA) using 2 different devices.
Dr. Musto and colleagues...
11/01/2021
Journal of Invasive Cardiology
04/29/2015

Paul T. Vaitkus, MD, MBA1,2;  Dee Dee Wang, MD1;  Mayra Guerrero, MD1;  Adam Greenbaum, MD1;  William O‚ÄôNeill, MD1

Paul T. Vaitkus, MD, MBA1,2;  Dee Dee...
Patients with atrial fibrillation and contraindications to anticoagulation have limited options for left atrial appendage (LAA) closure until approval of dedicated closure devices; off-label use of available cardiac devices represents one...
Patients with atrial fibrillation and contraindications to anticoagulation have limited options for left atrial appendage (LAA) closure until approval of dedicated closure devices; off-label use of available cardiac devices represents one...
Patients with atrial...
04/29/2015
Journal of Invasive Cardiology